News
53m
Axios on MSNChina's biotech boom leaves U.S. playing catch-upChina is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...
Earlier this year, biotech company 23andMe filed for bankruptcy. The harsh reality was that its business, while enticing to people who wanted to learn about their backgrounds via DNA testing kits, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results